Bio-Techne
TECH
#2188
Rank
HK$71.20 B
Marketcap
HK$455.11
Share price
-1.82%
Change (1 day)
-10.79%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): HK$4.04

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is HK$4.06. In 2024 the company made an earnings per share (EPS) of HK$7.81 a decrease over its 2023 EPS that were of HK$11.09.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$4.04-48.31%
2024HK$7.81-29.58%
2023HK$11.09-14.97%
2022HK$13.0524.16%
2021HK$10.5117.98%
2020HK$8.91-10.94%
2019HK$10.00101.57%
2018HK$4.96-16.99%
2017HK$5.9845.02%
2016HK$4.12-20.97%
2015HK$5.22-14.97%
2014HK$6.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$138.84 3,317.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$43.52 971.15%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$64.22 1,480.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
HK$39.61 875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
HK$15.37 278.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-HK$1.64-140.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-HK$189.94-4,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA